top of page
Leading the Way in Intratumoral Radiotherapeutics
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference
Jerusalem, March 16, 2026 - Alpha Tau Medical Ltd . (Nasdaq: DRTS, DRTSW) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® today announced that CFO Raphi Levy will present at the Sidoti Virtual Small Cap Conference taking place on March 18 - 19, 2026. Event: Sidoti Virtual Small Cap Conference Format: Company Presentation Date: March 18, 2026 Time: 10:00 – 10:30AM ET Location: Virtual Mr. Levy will be available for 1x1 investor meeti
5 days ago
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
Mar 9
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Certain Head and Neck Cancers
Feb 24
Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead
Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead
Jan 29
bottom of page